biocryst pharmaceuticals

Biocryst And 3DP Complement Agreement

BioCryst Pharmaceuticals, Inc. has transferred rights to specific classes of compounds that act as inhibitors of proteins and enzymes in the complement system to 3- Dimensional Pharmaceuticals, Inc. (3DP), a wholly owned subsidiary of Johnson & Johnson. BioCryst will receive an initial payment from 3DP, and will receive royalties on any future sales of complement Read more about Biocryst And 3DP Complement Agreement[…]

boston life sciences

Drug Delivery Device Supply Agreement For Boston Life Sciences And Codman & Shurtleff

Boston Life Sciences, Inc. has announced it has entered into an agreement with Codman & Shurtleff, Inc., a Johnson & Johnson subsidiary, related to BLSI’s development of Inosine for stroke. Under the agreement, Codman will supply BLSI with implantable pumps and catheters for BLSI’s preclinical and clinical studies for Inosine, and in exchange, Codman will Read more about Drug Delivery Device Supply Agreement For Boston Life Sciences And Codman & Shurtleff[…]

Photoelectron Announces Strategic Partnership With Cordis

Photoelectron Corporation has signed an exclusive agreement with Cordis Corporation, a Johnson & Johnson Company, to co-develop and co- manufacture a disposable miniature x-ray source and associated technology for the delivery of intravascular radiation therapy to prevent restenosis of coronary arteries following angioplasty and stent procedures. Cordis Corporation is a leader in circulatory disease management. Read more about Photoelectron Announces Strategic Partnership With Cordis[…]

Johnson &Johnson’s Epilepsy Drug Leads To Weight Loss

Johnson & Johnson have announced that obese patients lost over 11 percent of their body weight one year after being treated with the company’s anti-epilepsy drug Topamax.The firm is encouraged to continue developing the medicine as a weight-loss medicine.Topamax is currently approved only for treatment of epilepsy, but the New Brunswick, N.J.-based firm is also Read more about Johnson &Johnson’s Epilepsy Drug Leads To Weight Loss[…]